Lee Cooper’s Take on IVF+PGT: A Way to Prevent all Fatal Genetic Conditions such as Spinal Muscular Atrophy Type 1?

What if you could prevent all of the world's most fatal genetic diseases? According to Lee D. Cooper, there's a way- we're just not educating people on how to do…

Continue Reading Lee Cooper’s Take on IVF+PGT: A Way to Prevent all Fatal Genetic Conditions such as Spinal Muscular Atrophy Type 1?

Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope

Nontuberculous mycobacterial (NTM) lung infection occurs when someone inhales nontuberculous mycobacteria from the environment. There are various types of this bacteria, giving NTM different forms. But in all types of NTM,…

Continue Reading Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope
Potential Gene Therapies for Tay-Sachs, Sandhoff, and GM1 Gangliosidosis Now Have Worldwide Licenses
Source: Pixabay.com

Potential Gene Therapies for Tay-Sachs, Sandhoff, and GM1 Gangliosidosis Now Have Worldwide Licenses

Tay-Sachs disease and Sandhoff disease (also known as GM2 Gangliosidosis), and GM1 Gangliosidosis are neurodegenerative conditions. They are a result of a defective enzyme. This enzyme causes toxic gangliosides to accumulate within the…

Continue Reading Potential Gene Therapies for Tay-Sachs, Sandhoff, and GM1 Gangliosidosis Now Have Worldwide Licenses
New Orphan Drug Designation for Potential Spinocerebellar Ataxia Treatment
Source: Pixabay.com

New Orphan Drug Designation for Potential Spinocerebellar Ataxia Treatment

Spinocerebellar Ataxia (SCA) refers to a group of neurodegenerative disorders. Ataxias are a component of the nervous system which control movement. SCA occurs when the ataxias in the brain or spinal…

Continue Reading New Orphan Drug Designation for Potential Spinocerebellar Ataxia Treatment
This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019
Source: Pixabay.com

This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019

Familial adenomatous polyposis (FAP) is a condition which causes extra tissue to form in various parts of the body such as the large intestine and gastrointestinal track. FAP affects about…

Continue Reading This Just in: Data from Phase 3 Trial for Familial Adenomatous Polyposis is Coming Early 2019

CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders

Neurodegenerative disorders affect millions of people across the world. They include Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, among others. For most neurodegenerative diagnoses, there are no effective treatments, no…

Continue Reading CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders
Angelman Syndrome Clinic Network is Now International
https://pixabay.com/en/hands-world-map-global-earth-600497/

Angelman Syndrome Clinic Network is Now International

Angelman Syndrome (AS) is a neurogenetic disorder. It's not fatal, but prevents patients' from living independently. It causes neurological impairment, seizures, and balance issues among other problems. It's caused by a…

Continue Reading Angelman Syndrome Clinic Network is Now International
Charcot-Marie-Tooth: Misconceptions from People Who Just Don’t Know
Source: Pixabay.com

Charcot-Marie-Tooth: Misconceptions from People Who Just Don’t Know

Charcot-Marie-Tooth disease (CMT), is a rare neurological condition. It's hereditary, and it affects the way nerves communicate with muscles. There are different types of CMT, determined by which genes are…

Continue Reading Charcot-Marie-Tooth: Misconceptions from People Who Just Don’t Know